Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer

NCT04052113 · clinicaltrials.gov ↗
COMPLETED
Status
152
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca